"Practical and Pro Tips for Incorporating AI into Your Practice" with Rachel F. Brem, MD, FACR, FSBI, Director, Breast Imaging and Imaging, George Washington University (Saturday, April 26, 2025, 9:15 AM - 9:40 AM), will review practical considerations on why, how and when to implement AI into your breast clinical practice.
With 35+ peer-reviewed publications, Transpara is the only breast AI algorithm evaluated in large-scale real-world screening populations multiple times (including UCLA, Capital Region of Denmark, Lund University in Sweden, Norwegian Cancer Registry, Reina Sofia Hospital Cordoba). Results of the MASAI trial, demonstrate that Transpara-assisted workflow increased cancer detection by 29% and resulted in a 44% reduction in the screen-reading workload for radiologists.
Ad Statistics
Times Displayed: 18745
Times Visited: 357 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About ScreenPoint Medical
ScreenPoint Medical translates cutting edge machine learning research into technology accessible by radiologists to improve screening workflow, decision confidence and breast cancer risk assessment. Transpara is trusted by radiologists globally because it has been developed by experts in machine learning and image analysis and updated with user feedback from world-renowned breast imagers. See all the proof at: https://screenpoint-medical.com/evidence/
Back to HCB News
